About us
Trilateral Research is a UK - and IE-based SME founded in 2004. Our rigorous research is at the foundation of our work. We provide regulatory and policy advice; develop new data-driven technologies, including for the UK Public Sector. We focus our efforts on areas where the application of our research can make a difference in enhancing societal wellbeing. Our team extends to those with more than 20+ years working within the social science and data science research space; 80% of whom have postgraduate qualifications.
Research staff across Trilateral Research have extensive experience in conducting privacy, data protection, social, and ethical impact assessments to prevent and mitigate adverse impacts arising from new technology and practices. We also provide our project partners and clients with guidance and support in relation to research ethics and data management. Trilateral’s data governance services support organisations to navigate the latest regulations with confidence to maintain their high reputational standards and preserve trustworthy relationships with their clients and partners.
Learn more about us at www.trilateralresearch.com.
Main role in the project
As part of the iToBoS project, Trilateral Research conducts a comprehensive privacy impact assessment of the iToBoS technologies, to ensure appropriate and safe handling of patient data based on existing regulations at both European and national levels. The impact assessment ensures that the project considers specific privacy, data protection, ethical and social issues in relation to the iToBoS technologies. The envisioned integration of various data sources (medical records, genomics data, in vivo imaging) will directly target the reduction of inequalities in outcomes and diagnosis due to gender, age and ethnicity.
Trilateral Research will develop novel techniques for approaching transparency and deal with issues such as algorithmic bias and interpretability. To ensure public transparency, trust and accountability are addressed in the development of the AI-based decision support tool.
Finally, Trilateral Research will report on socio-cultural and ethical considerations to assist future decision-makers and stakeholders in using the new technologies in the dermatological context, ensure the inclusiveness of the implementation of the system, strengthen interactions between users and team members, and establish and increase trust for the technologies. Trilateral’s effort aims at empowering the sustainability of the project results by producing guidelines for healthcare professionals, patients, caregivers and receivers and related EU projects.